KEANDRA SPEAKMAN: Open Payments
NPI 1508561614 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 41 payments from 8 companies in 2025. Trend: 2023 $158 · 2024 $1,232 · 2025 $1,303
Food & beverage: $1,231Education: $73
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $637 |
| Teva Pharmaceuticals USA, Inc. | 6 | $221 |
| TG Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| SK Life Science, Inc. | 3 | $91 |
| Neurocrine BioSciences, Inc. | 3 | $71 |
| PFIZER INC. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
Products named: QULIPTA, VRAYLAR, AUSTEDO XR, UBRELVY, BRIUMVI, ZEPOSIA, INGREZZA, BOTOX.
Industry payments across MO — which companies pay providers there.
